131 related articles for article (PubMed ID: 8011723)
21. Pneumocystis pneumonia in people with HIV.
Bellamy R
Clin Evid; 2005 Jun; (13):854-68. PubMed ID: 16135282
[No Abstract] [Full Text] [Related]
22. [Clindamycin and primaquine in the treatment of pulmonary pneumocystosis in a HIV-positive female patient].
Zouiten F; Bouslama K; Gastli M; Tiouiri H; Battikh R; Ben Salem N; Ben Chaabane T; Chaker E; Ben Rachid MS; Zribi A
Ann Med Interne (Paris); 1993; 144(1):61-3. PubMed ID: 8503615
[No Abstract] [Full Text] [Related]
23. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Kay R; DuBois RE
South Med J; 1990 Apr; 83(4):403-4. PubMed ID: 2321069
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of severe pneumocystis pneumonia with clindamycin-primaquine in an HIV-negative patient.
Crisp HC; Stewart IJ; Blatz PJ; Rice DH; Okulicz JF
South Med J; 2009 Nov; 102(11):1161-3. PubMed ID: 19864989
[TBL] [Abstract][Full Text] [Related]
25. [Case Report: Clindamycin with Primaquine Therapy for Severe Pneumocystis Pneumonia].
Yoshimura Y; Sakamoto Y; Amano Y; Tachikawa N
Kansenshogaku Zasshi; 2015 Sep; 89(5):601-5. PubMed ID: 26630794
[TBL] [Abstract][Full Text] [Related]
26. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
Barber BA; Pegram PS; High KP
Clin Infect Dis; 1996 Oct; 23(4):718-22. PubMed ID: 8909833
[TBL] [Abstract][Full Text] [Related]
27. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.
Warren E; George S; You J; Kazanjian P
Pharmacotherapy; 1997; 17(5):900-16. PubMed ID: 9324180
[TBL] [Abstract][Full Text] [Related]
28. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
Safrin S
Semin Respir Infect; 1993 Jun; 8(2):96-103. PubMed ID: 8278684
[TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.
Smego RA; Nagar S; Maloba B; Popara M
Arch Intern Med; 2001 Jun; 161(12):1529-33. PubMed ID: 11427101
[TBL] [Abstract][Full Text] [Related]
30. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
31. Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review.
Benfield T; Atzori C; Miller RF; Helweg-Larsen J
J Acquir Immune Defic Syndr; 2008 May; 48(1):63-7. PubMed ID: 18360286
[TBL] [Abstract][Full Text] [Related]
32. Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients.
Nickel P; Schürmann M; Albrecht H; Schindler R; Budde K; Westhoff T; Millward J; Suttorp N; Reinke P; Schürmann D
Infection; 2014 Dec; 42(6):981-9. PubMed ID: 25168263
[TBL] [Abstract][Full Text] [Related]
33. Primaquine plus clindamycin as a promising salvage therapy for Pneumocystis jirovecii pneumonia: A retrospective analysis in Japanese patients.
Koga M; Suganuma A; Kikuchi T; Yoshimura Y; Shoji K; Kobayashi I; Takezaki S; Kato Y; Kimura M; Maruyama H;
J Infect Chemother; 2021 Jun; 27(6):924-928. PubMed ID: 33722465
[TBL] [Abstract][Full Text] [Related]
34. Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.
Roudier C; Caumes E; Rogeaux O; Bricaire F; Gentilini M
Arch Dermatol; 1994 Nov; 130(11):1383-6. PubMed ID: 7979438
[TBL] [Abstract][Full Text] [Related]
35. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
Morris-Jones SD; Easterbrook PJ
J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481
[No Abstract] [Full Text] [Related]
36. [Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
Pastor C; Lumbreras C; Lizasoain M
Med Clin (Barc); 1994 Oct; 103(12):473-6. PubMed ID: 7996899
[No Abstract] [Full Text] [Related]
37. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
38. [Adverse reactions to trimethoprim-sulfamethoxazole in AIDS patients].
Irazábal B; Camino E; Cid de Rivera C; Aguirrebengoa K; Urkijo JC
Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):429-32. PubMed ID: 8260515
[TBL] [Abstract][Full Text] [Related]
39. Lack of effect of prophylactic aerosolized pentamidine on the detection of Pneumocystis carinii in induced sputum or bronchoalveolar lavage specimens.
Ng VL; Geaghan SM; Leoung G; Shiboski S; Fahy J; Schnapp L; Yajko DM; Hopewell PC; Hadley WK
Arch Pathol Lab Med; 1993 May; 117(5):493-6. PubMed ID: 8489338
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure.
Liu A; Sun R; Cao G; Liu X; Zhu H; Yang J
BMC Infect Dis; 2022 Jun; 22(1):546. PubMed ID: 35701759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
